CompletedPhase 4NCT06466421

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Studying Uremic pruritus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tanta University
Principal Investigator: Sahar M El-Haggar, PhD, DDS
Tanta University
Intervention: Fexofenadine(drug)
Enrollment: 60 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2024

Study locations (1)

Tanta University, Tanta, Elgharbia, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06466421 on ClinicalTrials.gov

Other trials for Uremic pruritus

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06446310
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
Qilu Pharmaceutical (Hainan) Co., Ltd.

See all trials for Uremic pruritus →

← Back to all trials